These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3937212)

  • 21. Clinical development of oxamniquine in Egypt.
    Saif M; Gaber A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):18-27, 134-43. PubMed ID: 7455504
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neurotoxicity of oxamniquine in the treatment of human Schistosoma mansoni infection].
    de Carvalho SA; Shikanai-Yasuda MA; Amato Neto V; Shiroma M; Luccas FJ
    Rev Inst Med Trop Sao Paulo; 1985; 27(3):132-42. PubMed ID: 3938063
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxamniquine in the treatment of various schistosome infections in South Africa.
    Pitchford RJ; Lewis M
    S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of worm burdens in experimental schistosomiasis.
    Fulford AJ; Yeang F
    Parasitology; 1988 Oct; 97 ( Pt 2)():303-15. PubMed ID: 3143991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Field study of different oxamniquine dose for Schistosoma mansoni in Gezira, Sudan.
    Abdel Rahim IM; Haridi AA; Abdel-Hameed AA
    J Trop Med Hyg; 1988 Jun; 91(3):131-7. PubMed ID: 3134556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose-finding trials of oral oxamniquine in Rhodesia.
    de V Clarke V; Blair DM; Weber MC; Garnett PA
    S Afr Med J; 1976 Oct; 50(46):1867-71. PubMed ID: 996687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire.
    Polderman AM; Gryseels B; De Caluwe P
    Trans R Soc Trop Med Hyg; 1988; 82(1):115-6. PubMed ID: 3140441
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Field trials with oxamniquine in a Schistosomiasis mansoni-endemic area.
    Katz N; Zicker F; Pereira JP
    Am J Trop Med Hyg; 1977 Mar; 26(2):234-7. PubMed ID: 848645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of Schistosoma mansoni infection treated during the prepatent period.
    Enk MJ; Katz N; Zech Coelho PM
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):112-5. PubMed ID: 18253140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity.
    Botros S; Soliman A; el-Gawhary N; Selim M; Guirguis N
    Trans R Soc Trop Med Hyg; 1989; 83(1):86-9. PubMed ID: 2513673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of oxamniquine in the treatment of S. mansoni infection among Sudanese patients.
    Ibrahim AM
    East Afr Med J; 1980 Aug; 57(8):566-73. PubMed ID: 7408738
    [No Abstract]   [Full Text] [Related]  

  • 36. [Low effectiveness of an oxamniquine and praziquantel combination in the therapy of schistosomiasis mansoni].
    Dietze R; Prata A
    Rev Soc Bras Med Trop; 1986; 19(4):247-9. PubMed ID: 3150592
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 38. A trial of oral oxamniquine in the treatment of Schistosoma infection in children.
    Axton JH; Garnett PA
    S Afr Med J; 1976 Jun; 50(27):1051-3. PubMed ID: 951627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of mansonic schistosomiasis with oxamniquine (UK-4271)].
    Huggins D
    An Inst Hig Med Trop (Lisb); 1977-1978; 5(1-4):215-20. PubMed ID: 553457
    [No Abstract]   [Full Text] [Related]  

  • 40. Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia.
    de Clarke V
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):28-31, 144-7. PubMed ID: 7455506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.